Correlation Between Vaxxinity and Zenas BioPharma,
Can any of the company-specific risk be diversified away by investing in both Vaxxinity and Zenas BioPharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaxxinity and Zenas BioPharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaxxinity and Zenas BioPharma, Common, you can compare the effects of market volatilities on Vaxxinity and Zenas BioPharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaxxinity with a short position of Zenas BioPharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaxxinity and Zenas BioPharma,.
Diversification Opportunities for Vaxxinity and Zenas BioPharma,
-0.67 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Vaxxinity and Zenas is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Vaxxinity and Zenas BioPharma, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zenas BioPharma, Common and Vaxxinity is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaxxinity are associated (or correlated) with Zenas BioPharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zenas BioPharma, Common has no effect on the direction of Vaxxinity i.e., Vaxxinity and Zenas BioPharma, go up and down completely randomly.
Pair Corralation between Vaxxinity and Zenas BioPharma,
If you would invest 272.00 in Vaxxinity on September 13, 2024 and sell it today you would earn a total of 0.00 from holding Vaxxinity or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 1.59% |
Values | Daily Returns |
Vaxxinity vs. Zenas BioPharma, Common
Performance |
Timeline |
Vaxxinity |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Zenas BioPharma, Common |
Vaxxinity and Zenas BioPharma, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vaxxinity and Zenas BioPharma,
The main advantage of trading using opposite Vaxxinity and Zenas BioPharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaxxinity position performs unexpectedly, Zenas BioPharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zenas BioPharma, will offset losses from the drop in Zenas BioPharma,'s long position.Vaxxinity vs. Tarsus Pharmaceuticals | Vaxxinity vs. Aldeyra | Vaxxinity vs. Travere Therapeutics | Vaxxinity vs. Eton Pharmaceuticals |
Zenas BioPharma, vs. Dogwood Therapeutics, | Zenas BioPharma, vs. Elevation Oncology | Zenas BioPharma, vs. Elicio Therapeutics | Zenas BioPharma, vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |